- Country: USA
- Summary: J&A Procurement of Smallpox (Mpox) Vaccine for the Strategic National Stockpile
- UST Ref No: 81337121
- Deadline: 04 May 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: HHSO100201700019C
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
Description of Services or Supplies:
The total estimated value of the proposed action, including all options is $992,400,000.
BARDA awarded a contract to Bavarian Nordic (BN) on September 27, 2017 for the late- stage development and procurement of a lyophilized formulation of an MVA based smallpox vaccine. Contract options were also included to allow the procurement of the liquid frozen formulation of the vaccine, tradename JYNNEOS™ which can be filled faster during an emergency response. The JYNNEOS™ vaccine was granted licensure for the prevention of disease caused by smallpox and monkeypox making it the only vaccine ever licensed for the prevention of monkeypox.
Under the base period of the BARDA contract, BN completed the clinical evaluation of the lyophilized formulation and has transferred, optimized, and will soon validate the manufacturing process for the lyophilized vaccine. Under the base period and options, BN also manufactured and stockpiled batches of bulk drug substance (BDS) that can be used to fill/finish lyophilized or liquid frozen vaccine. As of May 2022, BARDA owned 164 batches of BDS (
16.4M dose equivalents).
Given that JYNNEOS™ is the only vaccine licensed to prevent monkeypox disease, it is the primary vaccine being used to stop the ongoing monkeypox outbreak. There is currently only a limited supply of JYNNEOS™ available (
550K filled vials).In response to the increasing number of cases of monkeypox within the US and globally, BARDA exercised several contract options (June - July 2022) to utilize existing BDS (55 batches ordered; 109 batches remain) to support the fill/finish of 5.5M doses of liquid frozen JYNNEOS™ vaccine. These doses will become available end CY 2022 and Q1 2023. On August 4, 2022, the Secretary of the Department of Health and Human Services declared the ongoing monkeypox outbreak a public health emergency. It is likely that additional doses (beyond 5.5M) of JYNNEOS™ may become urgen... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINJ&A Procurement of Smallpox (Mpox) Vaccine for the Strategic National Stockpile - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for J&A Procurement of Smallpox (Mpox) Vaccine for the Strategic National Stockpile. This tender is published on USARFP under UST Ref No: 81337121 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-05-04.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
